SB

Samsara BioCapital Portfolio holdings

AUM $766M
1-Year Est. Return 329.84%
This Quarter Est. Return
1 Year Est. Return
+329.84%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$729M
AUM Growth
+$208M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
47
New
Increased
Reduced
Closed

Top Buys

1
+$63.4M
2
+$36.4M
3
+$10.3M
4
PVLA
Palvella Therapeutics
PVLA
+$8.15M
5
OKUR
OnKure Therapeutics
OKUR
+$7.09M

Top Sells

1
+$50.8M
2
+$7.67M
3
+$6.39M
4
VRNA
Verona Pharma
VRNA
+$4.53M
5
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
+$3.84M

Sector Composition

1 Healthcare 99.03%
2 Financials 0.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$4.04M 0.55%
2,196,814
27
$2.94M 0.4%
291,666
28
$2.86M 0.39%
206,784
29
$1.95M 0.27%
630,000
30
$1.87M 0.26%
147,319
31
$1.41M 0.19%
198,000
32
$1.18M 0.16%
405,228
-135,076
33
$1.12M 0.15%
202,348
34
$827K 0.11%
399,637
-399,637
35
$607K 0.08%
+198,216
36
$603K 0.08%
11,263
-11,263
37
$561K 0.08%
52,458
38
$406K 0.06%
39,314
-16,291
39
$208K 0.03%
172,089
40
$74.2K 0.01%
78,131
41
$34.6K ﹤0.01%
3,580
42
$30.7K ﹤0.01%
133,333
43
$2.14K ﹤0.01%
99,999
44
– –
-3,640,015
45
– –
-35,000
46
– –
-1,786,427
47
– –
-689,709
1
2